Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Page 121 , June 2010

Seminars in fetal and neonatal medicine “continuing controversies in perinatal jaundice”

References 

  1. Blackmon LR, Fanaroff AA, Raju TNK. Research on prevention of bilirubin-induced brain injury and kernicterus: National institutes of child health and human development executive summary. Pediatrics. 2004;114:229–233
  2. Beutler E, Dern RJ, Flanagan CL, Alving AS. The hemolytic effect of primaquine, VII: biochemical studies of drug-sensitive erythrocytes. J Lab Clin Med. 1955;45:286–295
  3. Beutler E. The glutathione instability of drug-sensitive red cells: a new method for the in vitro detection of drug sensitivity. J Lab Clin Med. 1957;49:84–95
  4. Beutler E, Robson M, Buttenwieser E. The mechanism of glutathione destruction and protection in drug-sensitive and non-sensitive erythrocytes: in vitro studies. J Clin Invest. 1957;36:617–628
  5. Beutler E, Mitchell M. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood. 1968;32:816–818
  6. Beutler E, Gelbert T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism. Proc Natl Acad Sci USA. 1998;95:8170–8174
  7. Beutler E, Yeh M, Fairbanks VF. The normal human female as a mosaic of X-chromosome activity: studies using the gene for G-6-PD deficiency as a marker. Proc Natl Acad Sci USA. 1962;48:9–16
  8. Beutler E, Baluda MC. The separation of glucose-6-phosphate dehydrogenase-deficient erythrocytes from the blood of heterozygotes for glucose-6-phosphate dehydrogenase deficiency. Lancet. 1964;1:189–192

PII: S1744-165X(09)00119-X

doi: 10.1016/j.siny.2009.12.002

Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Page 121 , June 2010